You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019020
Jan 2020020
Feb 2020010
May 2020020
Jun 20200110
Jul 2020040
Aug 2020010
Sep 2020050
Nov 2020030
Dec 2020010
Jan 2021020
Feb 2021001
Mar 2021010
Apr 2021032
May 2021040
Jun 2021011
Jul 2021020
Aug 2021020
Sep 2021021
Oct 2021021
Nov 2021030
Dec 2021050
Jan 2022040
Feb 2022010
Mar 2022010
Apr 2022050
May 2022021
Jun 2022031
Jul 2022030
Aug 2022041
Sep 2022041
Oct 2022031
Nov 2022080
Dec 2022030
Jan 2023020
Feb 2023030
Mar 2023020
May 2023002
Jun 2023033
Jul 2023013
Aug 2023002
Sep 2023020
Oct 2023011
Nov 2023031
Dec 2023060
Jan 2024010
Feb 2024031
Mar 20240520
Total013244